Bio-Techne
TECH
#1834
Rank
C$16.19 B
Marketcap
C$103.28
Share price
0.01%
Change (1 day)
25.75%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2026 (TTM): C$1.63

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is C$1.67. In 2025 the company made an earnings per share (EPS) of C$0.74 a decrease over its 2024 EPS that were of C$1.43.

EPS history for Bio-Techne from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$1.63120.28%
2025C$0.74-48%
2024C$1.43-29.58%
2023C$2.02-14.97%
2022C$2.3824.16%
2021C$1.9217.98%
2020C$1.62-10.94%
2019C$1.82101.57%
2018C$0.91-16.99%
2017C$1.0945.02%
2016C$0.75-20.97%
2015C$0.95-14.97%
2014C$1.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
C$26.54 1,491.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
C$5.13 207.69%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$12.20 631.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
C$8.05 382.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
C$2.83 69.64%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
C-$0.30-117.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
C$11.87 611.97%๐Ÿ‡บ๐Ÿ‡ธ USA